By Investment U Research Team There are quite a few biotech stocks under $20 worth looking at. These are companies that are firmly out of penny territory, but might face growth headwinds. Nevertheless, there’s a reason investors are looking at them. They offer the promise of unlimited upside—most biotechs are just one drug away from major profitability. That said, they might also be one failed clinical trial away from becoming a penny stock. It’s the gamble investors take when they open a position in a low-cost biotech stock.
If you’re looking for companies that are more of a safe bet than a lottery ticket, here …read more
